Welcome to our new Lab Pinnacle Series. These roundtable articles will present ideas and insights on issues that impact labs, hospitals and health systems worldwide, from Sunquest and CliniSys subject matter experts across the globe.
Learn what to look for when selecting LIS technology for COVID-19 by reading Sunquest’s contribution to the Dark Daily special report, “Getting Paid for COVID-19 Test Claims: What Every Clinical Lab Needs to Know to Maximize Collected Dollars”
Sunquest’s best-of-breed technology is best suited to deliver on both immediate and evolving laboratory needs, particularly with regard to fighting COVID-19.
Laboratories implementing Sunquest’s gyn molecular interface have experienced dramatically improved efficiency, cost savings, and turnaround time.
The importance of COVID-19 contact tracing – that was the primary topic when Jonathan Pierson, Chief Operating Officer at Sunquest, hosted a roundtable discussion with two of Sunquest’s leading experts in epidemiology and public health.
Considering an enterprise-wide solution for lab operations? To further extend the value of the laboratory and support the organization’s strategic initiatives, consider these five factors when assessing enterprise-wide technology for lab operations.
As the health industry shifts from volume to value, patient outcomes are replacing revenue as a central measure of health system success. In response, lab leaders must think beyond their own cost centers and expand the lab’s capacity to support value-based strategic objectives.
Many healthcare facilities are looking to add or expand molecular testing capabilities in clinical labs. Explore the significant differences between clinical and molecular testing, and how they affect decisions about how to manage the complexity and voluminous data of a molecular lab.